United States· US:87143-100_262aa95f-9145-43a2-b144-41dd68fa6212

Attero

A medicinal product containing calcipotriene; betamethasone dipropionate, registered in United States by Perfero Pharma, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAtteroATC—REGISTER NO.US:87143-100_262aa95f…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CALCIPOTRIENE; BETAMETHASONE DIPROPIONATE
Manufacturer
Perfero Pharma, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    8714310060
    1 BOTTLE, PLASTIC in 1 CARTON (87143-100-60) / 60 g in 1 BOTTLE, PLASTIC
  • ndc11
    87143-100-60

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Calcipotriene; betamethasone dipropionate in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All calcipotriene; betamethasone dipropionate products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Aribec, Calcidermetha
  • Belgium · Crysalis, Dovobet
  • Bulgaria · Дайвобет, Енстилар
  • Cyprus · Dοvobet, Enstilar
  • Czechia · Enstilar, Talizon
  • Germany · Calcipotriderm Comp., Calcipotriol Comp
  • Denmark · Calcipotriol/Betamethasone "sandoz", Calcipotriol/Betamethasone Aristo
  • Estonia · Cabemet, Daivobet
  • Spain · Calcipotriol/Betametasona Aristo, Calcipotriol/Betametasona Ratiopharm
  • Finland · Calcipotriol/Betamethasone Sandoz, Daivobet
  • France · Calcipotriol/Betamethasone Sandoz, Closalis
  • United Kingdom (Northern Ireland) · Calcipotriol/Betamethasone, Calcipotriol/Betamethasone Sandoz
  • Greece · Dοvobet, Enstilar
  • Croatia · Daivobet, Enstilar
  • Hungary · Daivobet, Enstilar
  • Ireland · Calcipotriol/Betamethasone, Calcipotriol/Betamethasone Rowex
  • Iceland · Daivobet, Enstilar
  • Italy · Aribec, Calbeta
  • Lithuania · Cabemet, Daivobet
  • Luxembourg · Calcipotriol Comp, Closalis
  • Latvia · Cabemet, Daivobet
  • Malta · Cabemet, Daivobet
  • Netherlands · Calcipotriol/Betamethason Aristo, Calcipotriol/Betamethason Sandoz
  • Norway · Calcipotriol/Betamethasone Aristo, Calcipotriol/Betamethasone Orifarm
  • Poland · Betacal, Daivobet
  • Portugal · Betametasona + Calcipotriol Aristo, Closalis
  • Romania · Daivobet, Enstilum
  • Sweden · Calcipotriol/Betamethasone Aristo, Calcipotriol/Betamethasone Orifarm
  • Slovenia · Daivobet, Enstilum
  • Slovakia · Daivobet, Enstilar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6cd341f-9a0b-4628-9a04-2611cc70070c
GET /v1/drugs/c6cd341f-9a0b-4628-9a04-2611cc70070c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": ".05; .5",
  "substance": "CALCIPOTRIENE; BETAMETHASONE DIPROPIONATE",
  "productndc": "87143-100",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/g; mg/g",
  "application_number": "ANDA210765",
  "marketing_category": "ANDA"
}

See everything about calcipotriene; betamethasone dipropionate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.